Study of hydromorphone for older cancer patients with kidney problems
Part of Kidney & urinary, Pain, Women’s health & pregnancy clinical trials.
This trial tests a long-acting painkiller (hydromorphone) for older adults with cancer who have moderate-to-severe pain and some kidney issues. It aims to see if the drug is safe and works well for this group.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years or older
- You have been diagnosed with cancer
- You are not currently taking strong painkillers like morphine or oxycodone
- Your pain level is at least a 4 out of 10 (moderate to severe)
- Your kidneys function at a reduced or normal level (eGFR equal to or above 30)
- You are expected to live at least 3 more months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding non-opioid pain relievers (like dipyrone or ibuprofen) to opioid therapy can better manage cancer pain. It may help patients whose pain is not well controlled with opioids alone.
This study tests whether adding electroacupuncture (a treatment using mild electric pulses on needles) and ear acupressure (pressing on specific points on the ear) to the pain medicine hydromorphone helps reduce cancer-related pain that isn't well managed by usual treatments.
This Phase 2 study tests a new medicine (3D1002) taken together with extended-release oxycodone to improve moderate to severe cancer pain. You may be considered if your cancer pain is stable and you can follow the study’s strict pain-medication rules.
This trial tests a quick-acting pain medicine (hydromorphone) given through a vein to treat severe chest pain. It may be an option for people experiencing acute pain who haven't been helped by other medicines.
This trial compares two different pain medicines (methadone given by mouth or IV vs. hydromorphone given through a spinal injection) after surgery for gynecologic cancer. It aims to find which option provides better pain relief with fewer side effects.
This study tests a pain medicine called hydromorphone for people in the ICU who need a breathing tube. The goal is to see how well it works and if it's safe for managing pain and sedation.
Hear when a new Cancer Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.